MEHA
Functional Brands, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$0.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +3.2%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +3671.6%
- Operating cash flow
- +3649.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.1%
- EBITDA
- —
- EBIT
- —
- Net income
- +235.6%
- EPS
- +195.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026